arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Nuwellis, Inc.

NUWE
$4.62 ▼ -0.69 (-12.99%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
16 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

Nuwellis, Inc. faces fundamental challenges with weakness in Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.2M
Dividend Yield —
Revenue Growth -5.4% ↘
Op. Margin -134.3% ↘
ROIC -423.4% ↘
FCF / Share $-15.79
Trailing P/E —
Price / Book 3.0x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

16-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.27M
↓ -5.4% —
Net Income Profit after all expenses
$-17.52M
↓ -56.9% —
Operating Margin Operating profit as % of sales
-134.3%
↓ -6.8% 1th
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
1
Cash Quality ↓
45

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 16 years · 63 quarters